STK24 and neoplasm: Clearing NK cells with the anti‐PK136 antibody yielded no statistically significant tumor growth difference between the Ctrl and Stk24 KO LLC tumors (Figure 3G,H), suggesting that the anti‐tumor effect of STK24 deletion primarily depends on NK cells in the LLC tumor‐bearing model.